National Institute of Nursing Research

APSHO Welcomes Florida Cancer Specialists & Research Institute's Advanced Practitioners as APSHO Institutional Members

Retrieved on: 
Monday, October 30, 2023
Science, Hematology, Physician, University of Florida Cancer and Genetics Research Complex, Health, Journal, National Institute of Nursing Research, Cancer, Nurse practitioner, FCS, FNP, Patient, MSN, Evidence-based practice, Nursing

NEWTOWN, Pa., Oct. 30, 2023 /PRNewswire-PRWeb/ -- The Advanced Practitioner Society for Hematology and Oncology (APSHO) welcomes over 250 advanced practitioners—nurse practitioners and physician assistants—from Florida Cancer Specialists & Research Institute, LLC (FCS) as Institutional Members.

Key Points: 
  • Nurse practitioners and physician assistants from Florida Cancer Specialists & Research Institute, LLC join APSHO, a national network of health-care professionals devoted to a collaborative approach to cancer care.
  • NEWTOWN, Pa., Oct. 30, 2023 /PRNewswire-PRWeb/ -- The Advanced Practitioner Society for Hematology and Oncology (APSHO) welcomes over 250 advanced practitioners—nurse practitioners and physician assistants—from Florida Cancer Specialists & Research Institute, LLC (FCS) as Institutional Members.
  • "We applaud FCS' commitment to both patients and the advanced practitioners who care for them by joining APSHO as an Institutional Member," commented Wendy Vogel, FNP, AOCNP®, FAPO, APSHO's Executive Director.
  • APSHO, now over 5,000 members strong, is the only society dedicated to an interdisciplinary team approach to cancer treatment.

Feinstein Institutes secures $4M from NIH to study Black maternal health interventions

Retrieved on: 
Thursday, October 5, 2023
Research, Nursing, Women, Baby, Maternity, Managed Care, Health, Consumer, General Health, Science, Diagnosis, Woman, Incidence, Feinstein Institutes for Medical Research, Multimedia, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Disease, Doctor of Philosophy, Mother, Credit, Death, National Institute of Nursing Research, Bleeding, Pre-eclampsia, Organization, Northwell Health, Risk, Social support, MPH, Mortality, Maternal health, SMM, NINR, Feinstein, Comparison, Medical research, Black, Bangladesh Technical Education Board, Nursing Research, Birth control, MD

Researchers at The Feinstein Institutes for Medical Research at Northwell Health were awarded $4 million from the National Institute of Nursing Research (NINR), part of the National Institutes of Health, to study effective maternal health interventions.

Key Points: 
  • Researchers at The Feinstein Institutes for Medical Research at Northwell Health were awarded $4 million from the National Institute of Nursing Research (NINR), part of the National Institutes of Health, to study effective maternal health interventions.
  • View the full release here: https://www.businesswire.com/news/home/20231005320763/en/
    Feinstein Institutes’ Dr. Stephanie L. Fitzpatrick is co-principal investigator on the new research to study maternal health outcomes interventions.
  • Explore the role of physical activity from study enrollment to 1-year postpartum and subsequent association with maternal health outcomes.
  • In 2022, the health system formed its Center for Maternal Health , led by Dawnette Lewis, MD, MPH .

FCS Clinical Trials Lead to FDA Approval of New Targeted Drug for Patients with Mantle Cell Lymphoma

Retrieved on: 
Tuesday, February 14, 2023
AOCNP, MCL, NHL, Estate (law), Spleen, Drug development, National Institute of Nursing Research, FCS, Abstract, B-cell lymphoma, Reversibility, Diagnosis, Safety, Bone marrow, Hematology, Patient, Clinician Administered PTSD Scale, Liver, Lymph, Mantle cell lymphoma, Relapse, FACP, Clinical research, FDA, Growth, Prognosis, MSN, Progression-free survival, Society, BTK, Cancer, MD, Pharmaceutical industry, Vaccine

"It is rewarding to see the impact of our work in developing this drug from the initial trial."

Key Points: 
  • "It is rewarding to see the impact of our work in developing this drug from the initial trial."
  • - Manish Patel, MD
    Pirtobrutinib (Jaypirca™) is the first next-generation BTK inhibitor specifically approved by the FDA for adult patients with mantle cell lymphoma (MCL), a rare type of non-Hodgkin's lymphoma (NHL), which affects about one in 200,000 people worldwide each year.
  • Following an expedited review of the outcomes observed in the BRUIN 18001 study, the FDA granted Pirtobrutinib an accelerated approval.
  • To read the full study abstract: https://ash.confex.com/ash/2022/webprogram/Paper157058.html
    Access the current list of FCS clinical trials: https://flcancer.com/clinical-trials/

COVID-19 Vaccination Rates at NYC Schools Varied Significantly by Race/Ethnicity and Borough

Retrieved on: 
Thursday, September 15, 2022
MPH, National, NINR, White and Black: Crimes of Color, Gaps, Department, COVID-19, List of American Medical Association journals, Policy, Mental Hygiene, NYU Langone Health, New York City Department of Health and Mental Hygiene, Administration, 2009 Davis Cup, Department of Health and Mental Hygiene, Vaccination, Nursing Research, University of Delaware, White, National Institute of Nursing Research, Syracuse University, Student, Vaccine, JAMA Network Open, NYU, Population health, Public policy, Black, School, Research, School of Public Policy and Administration, University, New York University Grossman School of Medicine, Pharmaceutical industry, Tutoring, MD, COVID, Doctor of Philosophy, Medicine

Lagging furthest behind in COVID vaccination rates were schools attended by majority White and Black students, at 44 percent, while schools in Staten Island had lower vaccination rates, on average, than in any other borough.

Key Points: 
  • Lagging furthest behind in COVID vaccination rates were schools attended by majority White and Black students, at 44 percent, while schools in Staten Island had lower vaccination rates, on average, than in any other borough.
  • Reporting in the journal JAMA Network Open online September 15, after examining data from more than 1,500 NYC schools with an average of 980 students, the research team found that vaccination rates varied significantly by borough, ranging from the highest in Manhattan (59.7 percent) and lowest in Staten Island (38.6 percent).
  • Additionally, the researchers found that middle-high schools were more highly vaccinated (64.9 percent) than elementary schools (38.8 percent).
  • When broken down further, the data showed that while majority Asian schools had the highest vaccination rates regardless of borough, majority White schools in Manhattan (61.9 percent) and Brooklyn (49.1 percent) were more highly vaccinated than majority White schools in the Bronx (34.1 percent), Queens (28.5 percent), or Staten Island (25.4 percent).

NIAAA: Dr. Paule Joseph Selected as the Inaugural American Academy of Nursing Fellow at the National Academy of Medicine

Retrieved on: 
Wednesday, August 17, 2022
Pace University, Multimedia, Monell Chemical Senses Center, Disorder, Eating, Indiana University School of Nursing, NIH, Obesity, American Academy, Diagnosis, University, Annual general meeting, Policy, Smell, Leadership, National Institute of Nursing Research, Brain, National Institute, National academy, Research, Environment, Nursing Research, Health, Health equity, National Institute on Alcohol Abuse and Alcoholism, Patient, Academy, Health policy, Taste, Pangborn Sensory Science Symposium, Fellow, Biology, National Academy of Medicine, Culture, Master of Science in Health Informatics, NINR, AAN, Chemesthesis, NAM, NIAAA, Nursing, Metabolism, FAAN, Pharmaceutical industry, Veterinary medicine, Science, Alcoholism

M.S., FNP-BC, FAAN, is the inaugural 2022-2024 American Academy of Nursing (AAN) Fellow at the National Academy of Medicine (NAM).

Key Points: 
  • M.S., FNP-BC, FAAN, is the inaugural 2022-2024 American Academy of Nursing (AAN) Fellow at the National Academy of Medicine (NAM).
  • Dr. Joseph 's selection will be announced in person at the Annual Meeting of the NAM in Washington, D.C. on Monday, October 17.
  • "I congratulate Dr. Joseph on her selection for this first-of-its-kind fellowship," said George F. Koob, Ph.D., Director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA).
  • Dr. Joseph is a researcher at the NIAAA with a joint appointment at the National Institute of Nursing Research (NINR).

Florida Cancer Specialists & Research Institute Furthers Commitment to Clinical Research & Innovation, Next Generation Sequencing in Advancement of Cancer Care; Adds New In-House, Precision Oncology Capabilities

Retrieved on: 
Thursday, July 21, 2022
DNA, NGS, Microsatellite instability, Diagnosis, ASCO, Investment, FCS, RWD, GLOBE, Baylor University, Physician, MSN, Industry, Research, American Society of Clinical Oncology, Health, Database, Lymph, Marie Cassidy, RWE, CAPM, RN, National Institute of Nursing Research, Genetics, FACMG, News, Cancer, U.S. News & World Report, List of Shortland Street characters (1993), Gene, Leadership, Clinical trial, Immunotherapy, Disease, MD, AOCNP, Patient, Genetic testing, Precision medicine, Lymphatic system, Science, Testament, Translational research informatics, Doctor of Philosophy, OCN, LLC, University of Florida Cancer and Genetics Research Complex, Society, Medicine, Medical imaging, Pharmaceutical industry, Informatics

Ivenise holds a Ph.D. in Molecular and Human Genetics from Baylor College and has extensive experience in cancer genetics.

Key Points: 
  • Ivenise holds a Ph.D. in Molecular and Human Genetics from Baylor College and has extensive experience in cancer genetics.
  • Additionally, the statewide practice founded in 1984 is rapidly scaling its proprietary precision oncology knowledge base.
  • About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
    Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida.
  • The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.

AACN Board Chair Cynthia McCurren Testifies Before House Appropriations Subcommittee to Request Continued Support for Nursing Education and Research

Retrieved on: 
Thursday, May 26, 2022
Hospitals, Health, Other Education, Nursing, Education, Population, Nursing Research, Public health, United States House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, National Institute, Health, Investment, Title, NINR, Nursing, Human services, Association, United States Department of Health and Human Services, Patriot Act, Title VIII, Research, Workforce, American Association of Colleges of Nursing, FY, Committee, Student, Board, Congress, National Institute of Nursing Research, Human, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2015, Ageing, School, American Association, AACN, Education, Medicine, Labour

Throughout her testimony, Dr. McCurren outlined the current landscape of nursing education and underscored the essential need for further investments.

Key Points: 
  • Throughout her testimony, Dr. McCurren outlined the current landscape of nursing education and underscored the essential need for further investments.
  • AACN will continue to work with our Nursing Community Coalition partners and Congress to ensure that investments in nursing education, workforce, and research remain a top priority.
  • The American Association of Colleges of Nursing (AACN) is the national voice for academic nursing representing more than 850 schools of nursing nationwide.
  • AACN establishes quality standards for nursing education, influences the nursing profession to improve health care, and promotes public support of baccalaureate and graduate nursing education, research, and practice.

NIH Awards Visiting Nurse Service of New York $3.4 Million for Gender Affirmation Program Landmark Research

Retrieved on: 
Wednesday, August 18, 2021
Employment, Population, Program, Visiting Nurse Service of New York, Quality of life, Platinum, Center, GAP, Life, Nursing Research, Research, Columbia University School of Nursing, Mental health, Hospital, Multimedia, National, Patient, Healthcare and the LGBT community, National Institute of Nursing Research, NIH, National Institute, VNSNY, NINR, Gender identity, Medicine, Health insurance

The landmark study will address a significant gap in the current evidence on best practices to support gender minority individuals during a pivotal life course transition.

Key Points: 
  • The landmark study will address a significant gap in the current evidence on best practices to support gender minority individuals during a pivotal life course transition.
  • "This funding helps to strengthen the evidence base for improving healthcare access, outcomes and quality of life and mitigating pervasive disparities affecting this population," said Miriam Ryvicker.
  • Roughly 300 patients are being recruited for the study from VNSNY's Gender Affirmation Program (GAP) , a leading, specialized program designed to provide the best possible outcomes for patients undergoing gender affirmation surgery.
  • The VNSNY Gender Affirmation Program is designed to address each patient's unique needs before they leave the hospital and to provide a safe space for them to recuperate fully at home.